NEW YORK (GenomeWeb) – In March, the US National Academy of Medicine published a report on biomarkers and how the US government should take up a role in ensuring confidence in testing for precision medicine.

"I was sort of stunned when this report came out that it wasn't all over the press," said Garret Fitzgerald, a committee member and professor at the University of Pennsylvania.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.